Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis
- PMID: 11051135
- DOI: 10.1067/mjd.2000.109072
Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis
Abstract
Ciclopirox is a synthetic hydroxypyridone antifungal agent. In contrast to the azoles, glucuronidation is the main metabolic pathway of ciclopirox; therefore interactions with drugs metabolized via the cytochrome P450 system are unlikely Ciclopirox is also distinct from the common systemic agents, which interfere with sterol biosynthesis. In fact, ciclopirox chelates trivalent cations (such as Fe3+), inhibits metal-dependent enzymes that are responsible for degradation of toxic metabolites in the fungal cells, and targets diverse metabolic (eg, respiratory) and energy producing processes in microbial cells. Ciclopirox is a broad spectrum antimicrobial with activity against all the usual dermatophytes as well as yeast and nondermatophyte molds. It has demonstrated activity against gram positive and negative bacteria, including resistant strains of Staphlococcus aureus. Ciclopirox exhibits fungal inhibitory activity (minimum inhibitory concentration < 4 microg/mL for dermatophytes) as well as fungicidal activity; to date resistance to the drug has not been identified. Ciclopirox has been formulated in a nail lacquer delivery system. After evaporation of volatile solvents in the lacquer, the concentration of ciclopirox in the remaining lacquer film reaches approximately 35%, providing a high concentration gradient for penetration into the nail. Radiolabel data demonstrate penetration into infected nails after only 1 application of the lacquer. Ciclopirox nail lacquer is a topical product that provides an active fungicidal agent in a delivery system capable of promoting nail penetration. With repeated applications, the antifungal agent is homogeneously distributed through all layers of the toenail achieving concentrations of ciclopirox in excess of inhibitory and fungicidal concentrations for most pathogens. Although ciclopirox readily penetrates nails, very low levels of ciclopirox are recoverable systemically, even after chronic use. Ciclopirox nail lacquer 8% is a topical product that provides an active fungicidal agent in a delivery system capable of penetrating nails.
Similar articles
-
Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S70-80. doi: 10.1067/mjd.2000.109071. J Am Acad Dermatol. 2000. PMID: 11051136
-
The dermatopharmacologic profile of ciclopirox 8% nail lacquer.J Am Podiatr Med Assoc. 2000 Nov-Dec;90(10):491-4. doi: 10.7547/87507315-90-10-491. J Am Podiatr Med Assoc. 2000. PMID: 11107709
-
Development of ciclopirox nail lacquer with enhanced permeation and retention.Arch Pharm Res. 2016 Jul;39(7):953-9. doi: 10.1007/s12272-016-0774-0. Epub 2016 Jun 15. Arch Pharm Res. 2016. PMID: 27306785
-
Ciclopirox nail lacquer solution 8% in the 21st century.J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S96-102. doi: 10.1067/mjd.2000.109068. J Am Acad Dermatol. 2000. PMID: 11051138 Review.
-
Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.Drugs. 2010 Nov 12;70(16):2133-52. doi: 10.2165/11538110-000000000-00000. Drugs. 2010. PMID: 20964457 Review.
Cited by
-
Interaction between ciclopirox and acenocoumarol.Eur J Clin Pharmacol. 2013 Mar;69(3):727-8. doi: 10.1007/s00228-012-1347-x. Epub 2012 Jul 12. Eur J Clin Pharmacol. 2013. PMID: 22791274 No abstract available.
-
The antitumor activity of the fungicide ciclopirox.Int J Cancer. 2010 Nov 15;127(10):2467-77. doi: 10.1002/ijc.25255. Int J Cancer. 2010. PMID: 20225320 Free PMC article.
-
Polyurethanes as New Excipients in Nail Therapeutics.Pharmaceutics. 2018 Dec 13;10(4):276. doi: 10.3390/pharmaceutics10040276. Pharmaceutics. 2018. PMID: 30551686 Free PMC article.
-
Nail Society of India (NSI) Recommendations for Pharmacologic Therapy of Onychomycosis.Indian Dermatol Online J. 2023 Apr 27;14(3):330-341. doi: 10.4103/idoj.idoj_355_22. eCollection 2023 May-Jun. Indian Dermatol Online J. 2023. PMID: 37266092 Free PMC article. Review.
-
Pharmacokinetics of antifungal agents in onychomycoses.Clin Pharmacokinet. 2001;40(6):441-72. doi: 10.2165/00003088-200140060-00005. Clin Pharmacokinet. 2001. PMID: 11475469 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources